04/22/2026
Such disturbing news. Treat all people appropriately
This is a share from Professor Jim Nutbeam. Gender inequality is a real problem in healthcare. I knew about lower rates of bystander CPR and lower survival for women in prehospital cardiac arrest, and late recognition of cardiac emergencies, but this stat regarding hemorrhage management is shocking .
#
a headline.
Breakthrough drug reduces trauma mortality by 20-30%. Proven in over 30,000 patients. Works equally in men and women. Available now.
You’d want every trauma patient to receive it.
That drug exists. It’s tranexamic acid. It’s been available for years.
Now the data.
In a UK trauma registry analysis of over 200,000 patients: 16.8% of men received TXA. 7.3% of women did.
Women are 61% less likely to receive a drug that would benefit them equally.
This is not explained by injury severity. Not by mechanism. Not by bleeding risk.
When you control for all of these, the disparity remains. It widens with age.
Older women are the most undertreated group of all.
TXA loses 10% of its survival benefit for every 15 minutes of delay. Women who do receive it are also more likely to receive it later.
We are not talking about a knowledge gap. The evidence is unambiguous and has been for years.
We are talking about a practice gap. One that is, right now, costing lives.
The question that this data demands — and that nobody in trauma care has yet answered satisfactorily — is why.
We found a drug that saves lives equally in men and women.
Then we gave it to men.
